Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines

被引:0
|
作者
Fujishita, T [1 ]
Mizushima, Y [1 ]
Kashii, T [1 ]
Kobayashi, M [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 1, Sugitani, Toyama 93001, Japan
关键词
lung cancer; CDK inhibitor genes; K-ras p53;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin-dependent kinase (CDK) inhibitor genes have recently been proposed as new tumor suppressor genes. To define the possible participation of CDK inhibitor genes in lung carcinogenesis, we investigated the alterations of p15(INK4B), p16(INK4A), p21(Waf1), and p27(Kip1) genes in 34 human lung cancer cell lines using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), direct sequencing, and southern dot blot methods. Among the four CDK inhibitor genes, alterations of only the p16(INK4A) gene were found in 8 out of 34 (24%) cell lines, and all eight cell lines having a p16(INK4A) gene alteration had an alteration of either the K-ras or p53 gene. Conversely, p16(INK4A) gene alterations were found in none of the 3 cell lines having Rb gene alterations and none of the 3 cell lines having amplification of the N-myc gene. Polymorphism was found in both p21(Waf1) and p27(Kip1) genes, but no association was found between the polymorphism and alterations of other genes. These results suggest that p16(INK4A) gene alterations may play a certain role for lung carcinogenesis in co-operation with either K- ras orp53 gene alterations.
引用
收藏
页码:1537 / 1542
页数:6
相关论文
共 50 条
  • [1] p16INK4A/MTS1/CDKN2 -: the melanoma gene?
    Bogenrieder, T
    Landthaler, M
    Stolz, W
    HAUTARZT, 1998, 49 (02): : 91 - 100
  • [2] CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma
    Uchida, T
    Kinoshita, T
    Murate, T
    Saito, H
    Hotta, T
    LEUKEMIA & LYMPHOMA, 1998, 29 (1-2) : 27 - 35
  • [3] Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
    Zhao, Ran
    Choi, Bu Young
    Lee, Mee-Hyun
    Bode, Ann M.
    Dong, Zigang
    EBIOMEDICINE, 2016, 8 : 30 - 39
  • [4] Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors
    Kuerbitz, SJ
    Malandro, J
    Compitello, N
    Baylin, SB
    Graff, JR
    CELL GROWTH & DIFFERENTIATION, 1999, 10 (01): : 27 - 33
  • [5] ALTERATIONS OF CDKN2 (P16) IN NON-SMALL-CELL LUNG-CANCER
    DEVOS, S
    MILLER, CW
    TAKEUCHI, S
    GOMBART, AF
    CHO, SK
    KOEFFLER, HP
    GENES CHROMOSOMES & CANCER, 1995, 14 (03): : 164 - 170
  • [6] Analysis of p53/BAX/p16ink4a/CDKN2 in esophageal squamous cell carcinoma:: High BAX and p16nk4a/CDKN2 identifies patients with good prognosis
    Sturm, I
    Petrowsky, H
    Volz, R
    Lorenz, M
    Radetzki, S
    Hillebrand, T
    Wolff, G
    Hauptmann, S
    Dörken, B
    Daniel, PT
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2272 - 2281
  • [7] Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers
    Kim, JR
    Kim, SY
    Kim, MJ
    Kim, JH
    EXPERIMENTAL AND MOLECULAR MEDICINE, 1998, 30 (02): : 109 - 114
  • [8] Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers
    Jae-Ryong Kim
    Seong-Yong Kim
    Mi-Jin Kim
    Jung-Hye Kim
    Experimental & Molecular Medicine, 1998, 30 : 109 - 114
  • [9] Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas
    Serrano, J
    Goebel, SU
    Peghini, PL
    Lubensky, IA
    Gibril, F
    Jensen, RT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4146 - 4156
  • [10] Genetic alterations of P16INK4A and P14ARF genes in human bladder cancer
    Chang, LL
    Yeh, WT
    Yang, SY
    Wu, WJ
    Huang, CH
    JOURNAL OF UROLOGY, 2003, 170 (02): : 595 - 600